Evidence map›Paper›PMID 35703605›Full record

ReviewRevista de saude publica2022

Hospitalizations from covid-19: a health planning tool.

Miguel Santolino, Manuela Alcañiz, Catalina Bolancé

Abstract readReview
In one paragraph

Review in Revista de saude publica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Miguel SantolinoUniversitat de Barcelona. Institut de Recerca en Economia Aplicada. Research Group on Risk in Insurance and Finance. Barcelona, España.ORCID http://orcid.org/0000-0002-0286-3673
Manuela AlcañizUniversitat de Barcelona. Institut de Recerca en Economia Aplicada. Research Group on Risk in Insurance and Finance. Barcelona, España.ORCID http://orcid.org/0000-0002-5028-1926
Catalina BolancéUniversitat de Barcelona. Institut de Recerca en Economia Aplicada. Research Group on Risk in Insurance and Finance. Barcelona, España.ORCID http://orcid.org/0000-0002-5982-1538

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveEstimate the future number of hospitalizations from Covid-19 based on the number of diagnosed positive cases.

methodUsing the covid-19 Panel data recorded in Spain at the Red Nacional de Vigilancia Epidemiológica, Renave (Epidemiological Surveillance Network), a regression model with multiplicative structure is adjusted to explain and predict the number of hospitalizations from the lagged series of positive cases diagnosed from May 11, 2020 to September 20, 2021. The effect of the time elapsed since the vaccination program starting on the number of hospitalizations is reviewed.

resultsNine days is the number of lags in the positive cases series with greatest explanatory power on the number of hospitalizations. The variability of the number of hospitalizations explained by the model is high (adjusted R2: 96.6%). Before the vaccination program starting, the expected number of hospitalizations on day t was 20.2% of the positive cases on day t-9 raised to 0.906. After the vaccination program started, this percentage was reduced by 0.3% a day. Using the same model, we find that in the first pandemic wave the number of positive cases was more than six times that reported on official records.

conclusionsStarting from the covid-19 cases detected up to a given date, the proposed model allows estimating the number of hospitalizations nine days in advance. Thus, it is a useful tool for forecasting the hospital pressure that health systems shall bear as a consequence of the disease.

Indexed as

COVID-19BrazilHealth PlanningHospitalizationHumansPandemicsUnited States

Identifiers

PMID35703605
PMCPMC9239335

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.